redalpine
VC Fund
Zürich, Switzerland
redalpine is a VC fund in Zürich focused on Biotechnology and Health Care. redalpine is the Swiss venture capital firm that empowers GameChangers. Founded in 2006, redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. With over €1bn in assets under management, the firm has backed some of Europe’s mostdisruptive software and science companies, including N26, Taxfix, Inkitt, 9fin, Carvolution, vivenu, and Infinite Roots. redalpine has over 95 companies in its portfolio and invests Europe-wide from its offices in Zurich and Berlin.
- Total investments:
- 201
- Last investment:
- Lead investor:
- 38%
- Fund size:
- $200M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries redalpine invests in
Stages redalpine invests in
Countries redalpine invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $1.6M–$13M
- Series A
- $3.2M–$33M
- Series B
- $16M–$125M
Investment Focus
Industry
- Biotechnology 15 (7%)
- Health Care 13 (6%)
- Software 12 (6%)
- Artificial Intelligence 12 (6%)
- Financial Services 10 (5%)
Stage
- Seed 47 (23%)
- Series A 44 (22%)
- Series B 22 (11%)
- Funding Round 11 (5%)
- Pre-Seed 8 (4%)
Country
- Germany 34 (17%)
- Switzerland 22 (11%)
- United Kingdom 12 (6%)
- United States 3 (1%)
- Spain 2 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Daniel Dillinger
Principal
|
Principal | Total investments: 2 | Find email | |
Gianmarco Hodel
Associate
|
Associate | Total investments: 5 | Find email | |
Harald Nieder
General Partner
|
General Partner | Total investments: 23 | Find email | |
Michael Sidler
Co-Founder & Partner
|
Co-Founder & Partner | Total investments: 15 | Find email | |
Michelle Kuepper
Head of Communications; Head of Communications
|
Head of Communications; Head of Communications | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Arlequin AI provides an AI-native platform for critical decision-making and high-stakes data analysis. Its technology uses unsupervised and topological AI to identify patterns, relationships, trends, and causal links across large datasets without generating text or relying on context windows. The platform supports applications including financialanalysis, forensics, due diligence, logistics, supply chain analysis, cybersecurity, and intelligence. | $32.6M / Series A / Sep 10, 2026 | ||
| Telli builds AI voice agents to automate pre-sales outreach for B2C companies, converting leads into sales opportunities. | $15M / Seed / Jul 23, 2026 | ||
| Full stack data solutions for embodied AI solutions. | $55M / Seed / Jul 16, 2026 | ||
| Proxima Fusion is a fusion energy company developing stellarator-based fusion power plants to deliver safe, carbon-free, and commercially viable electricity. The company focuses on commercializing quasi-isodynamic (QI) stellarators, a type of magnetic confinement fusion reactor designed to provide continuous and stable plasma operation. ProximaFusion collaborates closely with research institutions, industrial partners, and energy companies across Europe through the Alpha Alliance, a consortium established to scale the manufacturing and engineering capabilities needed for commercial fusion. The company leverages scientific breakthroughs from the Wendelstein 7-X (W7-X) stellarator while developing proprietary engineering, simulation, and manufacturing technologies to industrialize fusion power generation. | $470.1M / Series B / Jul 07, 2026 | ||
| Tokura focused on redesigning outpatient surgery (Ambulantes Operieren) through an integrated system of specialised facilities, experienced teams, and automated technology. | Seed / Jun 09, 2026 | ||
|
Apoha
|
Stealth stage start-up | $36M / Venture - Series Unknown / Jun 03, 2026 | |
| Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging. | $23M / Series A / Apr 29, 2026 | ||
| Helical is an intermediary platform that offers bioinformaticians free access to the technologies from AI and biological computation. | $10M / Seed / Apr 13, 2026 | ||
| 9fin uses artificial intelligence to automatically extract key information from bond & loan documentation. By making data easy to search, filter and analyse, 9fin helps fixed income professionals make better, smarter decisions.Our predictive analytics help forecast key capital markets events with a high degree of accuracy (100% record in2018); these include defaults, ratings changes, refinancing & recapitalisation transactions.In 2019, 9fin's analytics, real-time news and comprehensive financial data has: - Helped Banks & Law firms win new mandates - Allowed Funds to spot trading opportunities / credit risk - Enabled Sponsors to extract maximum value from their portfolioUsed by world leading banks, hedge funds and asset managers. Backed by leading VC funds & the only fintech in Europe accepted onto Google's AI residency program. Selected for IA Velocity program, first ever accelerator run by the Investment Association whose members manage £7.7 trillion AUM | $170M / Series C / Mar 31, 2026 | ||
| Flexion Robotics develops an AI-driven autonomy platform for humanoid robots to enhance automation and space exploration. The company uses simulated environments and reinforcement learning to train robots for different tasks. Its software stack integrates reinforcement learning, language-based reasoning, vision-language-action models, andtransformer-based whole-body control to enable robots to understand instructions, adapt to new environments, and perform complex tasks without extensive human teleoperation. The company trains its models in high-fidelity simulators to generate synthetic data at scale, reducing reliance on human demonstrations. | $49.6M / Series A / Nov 20, 2025 | ||
| See all 201 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does redalpine invest in?
redalpine invests primarily in Biotechnology, Health Care and Software startups, most often at Seed and Series A stage. Most of the 201 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is redalpine's check size?
redalpine typically joins rounds of $1.6M–$13M at Seed, $3.2M–$33M at Series A and $16M–$125M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds redalpine participates in.
How do I contact redalpine?
Public channels for redalpine include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at redalpine?
The team at redalpine includes Daniel Dillinger (Principal), Gianmarco Hodel (Associate) and Harald Nieder (General Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
